Clinical trials in Roznava

33 clinical trials in Roznava, Slovakia. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in SlovakiaKlinickeSkusky.sk

Roznava at a glance

clinical trials

Paediatric trials0
Research sites0

Quick filters

33 trials in Roznava

Open in trial search

Arteriosclerosis

Recruiting

Investigational

Study of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease

Investigational

Slovakia

Participants:18–64 years · 65+ years
Substances:Maridebart Cafraglutide
Sponsor:Amgen Inc.

Contact Research Centre

Type 2 diabetes mellitus

Recruiting

Registered drug

A study to assess the effect of elecoglipron alone and in combination with dapagliflozin on blood sugar control in adults with Type 2 diabetes

Registered drug

Slovakia

Participants:18–64 years · 65+ years
Substances:Azd5004
Sponsor:AstraZeneca AB

Contact Research Centre

Arteriosclerosis

Recruiting

InvestigationalNo placebo

Long-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial

InvestigationalNo placebo

Slovakia

Participants:18–64 years · 65+ years
Substances:Pelacarsen
Sponsor:Novartis Pharma AG

Contact Research Centre

Hypertriglyceridaemia

Recruiting

Investigational

Study of Plozasiran to prevent acute pancreatitis in adults with severe hypertriglyceridemia

Investigational

Slovakia

Participants:18–64 years · 65+ years
Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
Sponsor:Arrowhead Pharmaceuticals Inc.

Contact Research Centre

Cardiac failure chronic+1

Recruiting

Registered drugNo placebo

Study on Ferric Derisomaltose for Patients with Iron Deficiency and Chronic Heart Failure

Registered drugNo placebo

Slovakia

Participants:18–64 years · 65+ years
Substances:Ferric Derisomaltose
Sponsor:Pharmacosmos A/S

Contact Research Centre

Effect of lenbelintide (AZD6234) on body weight in adults with type 2 diabetes and obesity or overweight

Not yet recruiting

Investigational

Effect of lenbelintide (AZD6234) on body weight in adults with type 2 diabetes and obesity or overweight

Investigational

Slovakia

Participants:18–64 years · 65+ years
Substances:AZD6234
Sponsor:AstraZeneca AB

Contact Research Centre

Obesity

Not recruiting

Investigational

Efficacy and Safety of MET097 Once Weekly in People with Overweight or Obesity and Type 2 Diabetes

Investigational

Slovakia

Participants:18–64 years · 65+ years
Sponsor:Metsera Inc.

Contact Research Centre

Obesity

Not recruiting

Investigational

A study to evaluate the efficacy and safety of MET097 in people with obesity or overweight.

Investigational

Slovakia

Participants:18–64 years · 65+ years
Sponsor:Metsera Inc.

Contact Research Centre

Arteriosclerosis

Not recruiting

Investigational

A study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)

Investigational

Slovakia

Participants:18–64 years · 65+ years
Sponsor:Amgen Inc.

Contact Research Centre

Type 2 diabetes mellitus+3

Not recruiting

Registered drug

A study testing cagrilintide and semaglutide combination for kidney damage in people with chronic kidney disease and type 2 diabetes who are overweight or obese

Registered drug

Slovakia

Participants:18–64 years · 65+ years
Substances:Cagrilintide
Sponsor:Novo Nordisk A/S

Contact Research Centre

Hypercholesterolaemia

Not recruiting

Investigational

Study of AZD0780 in patients with high cholesterol and heart disease or risk of heart disease to lower bad cholesterol levels

Investigational

Slovakia

Participants:18–64 years · 65+ years
Sponsor:AstraZeneca AB

Contact Research Centre

Hypertriglyceridaemia

Not recruiting

InvestigationalNo placebo

Long-Term Safety Study of Plozasiran for Adults with High Triglycerides

InvestigationalNo placebo

Slovakia

Participants:18–64 years · 65+ years
Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
Sponsor:Arrowhead Pharmaceuticals Inc.

Contact Research Centre

Other cities in Slovakia

The busiest research cities in the country

All 92 cities in Slovakia

Clinical research in Roznava

What the registry says about research in the country

01 Cardiovascular Research

Innovative trials focusing on cardiovascular disease prevention and treatment, including studies on heart failure prevention and atherosclerosis management.

Heart failure prevention studies
Atherosclerotic cardiovascular disease treatments
Major cardiovascular events reduction

Research exploring new therapeutic approaches for reducing cardiovascular risks and improving patient outcomes.

02 Metabolic Disorders

Comprehensive research targeting Type 2 Diabetes and metabolic conditions, with particular focus on innovative treatment approaches.

Diabetes management therapies
Hypertriglyceridemia treatments
Obesity interventions

Studies evaluating new medications for glycemic control and metabolic regulation.

03 Renal Studies

Advanced research in chronic kidney disease management, focusing on novel therapeutic combinations and disease progression.

Proteinuria reduction strategies
Kidney function preservation
Combined therapy approaches

Investigating innovative treatments to slow kidney disease progression and improve outcomes.

Back to Slovakia All countries